Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β-Reference-Cited by-同舟云学术

Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β

Published:2017-02-27 Issue:9 Volume:13 Page:1004-1012
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Mormino Elizabeth C.¹,Papp Kathryn V.¹²,Rentz Dorene M.¹²,Donohue Michael C.³,Amariglio Rebecca¹²,Quiroz Yakeel T.¹⁴⁵,Chhatwal Jasmeer¹,Marshall Gad A.¹²,Donovan Nancy⁵,Jackson Jonathan¹,Gatchel Jennifer R.⁵,Hanseeuw Bernard J.¹,Schultz Aaron P.⁴⁶,Aisen Paul S.³,Johnson Keith A.¹²⁶⁷,Sperling Reisa A.¹²⁶

Affiliation:

1. Department of Neurology, Massachusetts General Hospital Harvard Medical School Boston MA USA

2. Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital Harvard Medical School Boston MA USA

3. Department of Neurology, Alzheimer's Therapeutic Research Institute University of Southern California San Diego CA USA

4. Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital Charlestown MA USA

5. Department of Psychiatry, Massachusetts General Hospital Harvard Medical School Boston MA USA

6. Department of Radiology, Massachusetts General Hospital Harvard Medical School Boston MA USA

7. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital Harvard Medical School Boston MA USA

Funder

National Institute on Aging

NIA

NIH

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2017.01.018

Reference42 articles.

1. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

2. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Amyloid- assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

4. Amyloid deposition, hypometabolism, and longitudinal cognitive decline

5. Effect of amyloid on memory and non‐memory decline from preclinical to clinical Alzheimer's disease;Lim YY;Brain,2013

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Association of Worry With Amyloid-β But Not Tau in Cognitively Unimpaired Older Adults;The American Journal of Geriatric Psychiatry;2024-10

2. Digital cognitive assessments as low‐burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum;Alzheimer's & Dementia;2024-09-06

3. Blood p-tau association with cognitive status and future memory decline in early Alzheimer’s disease;2024-08-07

4. Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults;BMJ Open;2024-08

5. Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures;Alzheimer's & Dementia;2024-07-04